Suzanne Hodgkinson

Royal Brisbane and Women's Hospital — Australia

Medicine · Health Sciences

46h-index8.1kcitations270works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(116), Immune Cell Function and Interaction(38), T-cell and B-cell Immunology(37), Immunotherapy and Immune Responses(37), Polyomavirus and related diseases(29)

Publications264 total

Managing reactivation of multiple sclerosis during treatment with natalizumab
Multiple Sclerosis Journal·2025Open Access
Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region
Multiple Sclerosis and Related Disorders·2025
Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis
Journal of Neurology Neurosurgery & Psychiatry·2025
3614 Preserving neurological function in people at high and low risk of aggressive multiple sclerosis
2025Open Access
3544 Long-term ofatumumab treatment over 6 years did not increase the risk of serious infections
2025Open Access
3652 Bilateral optic neuropathy secondary to golimumab: a case report and review
2025Open Access
YI6 MS outcomes in breast cancer survivors and the influence of chemotherapy
2025Open Access
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability
JAMA Network Open·2025Open Access
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis
Brain·2025· 2 citedOpen Access
T Regulatory Cell Phenotypes in Renal Transplant Patients with Long Surviving Graft: Increased Th2-Like Treg and Reduced Th1- and Th17-Like Treg
American Journal of Transplantation·2025
Expression of T Regulatory Cell Effector Molecules, CD39, HLA-DR and PD-1 in Renal Transplant Patients with Long Surviving Graft, Not Different to Healthy Volunteers
American Journal of Transplantation·2025
Human CD4+CD25+CD127lo Treg Have Enhanced Expression of IL-12Rb1 Upon Activation with Alloantigen and rIL-2
American Journal of Transplantation·2025
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study
Therapeutic Advances in Neurological Disorders·2025· 5 citedOpen Access
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)
Multiple Sclerosis Journal·2025Open Access
Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study
Neurology and Therapy·2025Open Access
Frequency and stability of populations of <scp>CD4</scp><sup>+</sup> and <scp>CD4</scp><sup>+</sup><scp>CD25</scp><sup>+</sup>Foxp3<sup>+</sup><scp>CD127<sup>lo</sup></scp> Treg in healthy adults defined by cytometry using monoclonal antibodies to T cell associated molecules
Cytometry Part B Clinical Cytometry·2025· 1 citedOpen Access
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis
JAMA Neurology·2025· 20 citedOpen Access
Autoantigen and IL-2 activated CD4+CD25+T regulatory cells are induced to express CD8 and are autoantigen specific in inhibiting experimental autoimmune encephalomyelitis
Journal of Neuroimmunology·2025· 1 cited
Efficacité à long terme de la Cladribine comprimé (CladT) sur 4 ans dans la sclérose en plaques récurrente (SEP R) : résultats de l’étude d’extension MAGNIFY-MS
Revue Neurologique·2025
Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
Frontiers in Immunology·2025· 1 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Jeannette Lechner‐Scott(21), Helmut Butzkueven(21), Eva Havrdová(20), Pierre Grammond(19), Pamela McCombe(19), Dana Horáková(18), Marc Girard(18), François Grand’Maison(18), Mark Slee(18), Tomáš Kalinčík(18), Guillermo Izquierdo(17), Pierre Duquette(17), Michael Barnett(17), Alessandra Lugaresi(16), Raed Alroughani(16), Cavit Boz(16), Vilija Jokubaitis(15), María Trojano(15), Vincent Van Pesch(15), Daniele Spitaleri(15)